how many americans are on glp-1 Just taking GLP-1s now America's Most Talked-About Drug Has
Description
Both tirzepatide and semaglutide are well-characterised in type 2 diabetes research models, with extensive phase 3 trial data supporting their use in glycaemic endpoint studies
Because their peaks are lower and persistent, some patients find them more tolerable (less severe nausea spikes), though they still cause significant GI side effects in many
In clinical studies of FDA-approved semaglutide and tirzepatide, meaningful weight loss typically became evident by 8-12 weeks
Though this looks impressive, the bigger question may be access
They work by mimicking a naturally occurring hormone in the body, increasing insulin production, and slowing down gastric emptying all of which work to reduce appetite and make you feel full
Treatment Duration: The Long Game Microdosing is rarely a quick fix
